A new classification for hepatocellular carcinoma with portal vein tumor thrombus
Author:
Affiliation:
1. Eastern Hepatobiliary Surgery Hospital; The Second Military Medical University; 225 Changhai Road Shanghai People's Republic of China
2. Faculty of Medicine; The Chinese University of Hong Kong; Shatin Hong Kong SAR China
Publisher
Wiley
Subject
Hepatology,Surgery
Reference16 articles.
1. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China;Zhang;Int J Epidemiol,1998
2. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-a for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis;Chung;Cancer.,2000
3. Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma;Qiang;World J Surg,2006
4. Surgical treatment of primary liver cancer-reported 5524 patients;Wu;Chin J Surg,2001
5. Do the tumor cells for hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection?;Yamanaka;Cancer.,1992
Cited by 152 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Expanding Indications for Surgical Resection in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01
2. Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombus;Frontiers in Oncology;2023-12-19
3. Efficacy and safety of regorafenib as second-line treatment for patients with hepatocellular carcinoma and macrovascular invasion and(or) extrahepatic metastasis;Journal of Gastrointestinal Oncology;2023-12
4. Current Diagnosis and Treatment for Hepatocellular Carcinoma with Macrovascular Tumor Thrombosis;Current Chinese Science;2023-12
5. Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis;Brachytherapy;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3